A major discovery is upending what neurologists have believed about Parkinson's disease for decades. A new Finnish study of 414 patients shows that rest tremor, one of the hallmark symptoms of Parkinson's, is not caused by greater dopamine loss in the brain. Instead, tremor appears to be associated with relatively better-preserved dopamine function. This finding suggests that tremor arises from a completely different biological mechanism than other Parkinson's symptoms, opening the door to more targeted treatments. What Makes This Discovery So Surprising? For decades, neurologists assumed all Parkinson's motor symptoms stemmed from the same root cause: the degeneration of dopamine-producing neurons in the brain. Dopamine is a chemical messenger that helps control movement, and when it declines, patients develop slowness of movement (bradykinesia), muscle stiffness (rigidity), and tremors. The logic seemed straightforward. But the new research challenges this one-size-fits-all explanation. Researchers from the University of Turku and Turku University Hospital analyzed dopamine transporter (DAT) imaging data from 414 Finnish patients examined in routine clinical practice. The study, published in March 2026 in Neurology, the journal of the American Academy of Neurology, revealed a striking pattern: rest tremor was associated with higher dopamine transporter binding in the striatum on the same side as the tremor. In contrast, bradykinesia and rigidity showed the expected correlation with dopamine deficits in the opposite hemisphere. "These results show that more severe rest tremor is not simply a marker of more advanced damage to the dopamine system. Tremor appears to involve a partly distinct neurobiological mechanism," said Kalle Niemi, MD, PhD, lead author and neurologist. Kalle Niemi, MD, PhD, Neurologist at University of Turku How Does This Change Our Understanding of Parkinson's? This discovery fundamentally reframes Parkinson's disease as a more complex disorder than previously understood. Rather than a single disease affecting one brain system, Parkinson's involves alterations across multiple neural networks and neurotransmitter systems. The research team used the same analytical framework to examine non-motor symptoms like depression, anxiety, and REM sleep behavior disorder. They found that these symptoms are primarily linked to monoaminergic systems other than dopamine, further supporting the idea that different Parkinson's symptoms have different biological roots. The findings were so robust that the team replicated them in an independent cohort. They had first observed this pattern using data from the international Parkinson's Progression Markers Initiative (PPMI), and then confirmed it in the Finnish clinical cohort. This replication in a real-world clinical setting strengthens confidence in the results. Why This Matters for Patients and Treatment Understanding that tremor operates through a different mechanism than other Parkinson's symptoms could revolutionize how doctors approach treatment. Currently, most Parkinson's medications focus on boosting dopamine levels, which works well for bradykinesia and rigidity but may not be the best approach for tremor. If tremor involves a distinct neurobiological pathway, doctors could eventually develop targeted therapies that address tremor specifically, rather than relying on one-size-fits-all dopamine replacement. "Our findings support the view that different symptoms of Parkinson's disease may be driven by partly distinct neural network and neurotransmitter mechanisms. This may help explain why tremor behaves differently from symptoms such as bradykinesia," explained Kalle Niemi. Kalle Niemi, MD, PhD, Neurologist at University of Turku How Might Doctors Use This Information? - Personalized Treatment Plans: A more precise understanding of which symptoms are driven by which brain mechanisms could enable doctors to tailor treatments to each patient's specific symptom profile, rather than prescribing the same medications to everyone. - Development of New Therapies: Pharmaceutical researchers could now focus on developing drugs that target the specific neural networks involved in tremor, potentially offering better symptom control for patients who don't respond well to dopamine-based treatments. - Better Prediction of Symptom Progression: If tremor and other motor symptoms arise from different mechanisms, doctors might be able to predict which symptoms will develop in individual patients and adjust treatment strategies accordingly. What Does This Mean for Living With Parkinson's? For people living with Parkinson's, this research offers hope that future treatments could be more effective and personalized. The discovery also validates the experience of many patients who notice that their tremor behaves differently from their other symptoms. Some patients find that their tremor improves with dopamine-boosting medications while their stiffness persists, or vice versa. This new understanding explains why those inconsistencies occur. Sue Goldie, a Harvard public health professor diagnosed with Parkinson's in 2021, has become an advocate for sharing the lived experience of the disease. Her openness about the challenges of Parkinson's has resonated with hundreds of patients who felt seen by her story. She emphasizes that Parkinson's plays out differently in everyone, from the initial symptoms to the timeline of progression. This new research supports that reality by showing that the biological mechanisms underlying different symptoms are distinct. The path forward involves continued research to fully understand these separate mechanisms and develop treatments that can target them. But for now, this discovery represents a significant shift in how scientists and doctors think about Parkinson's disease. Rather than viewing it as a single condition caused by dopamine loss, they now recognize it as a multifaceted disorder requiring a more nuanced, personalized approach to care.
